Search results
Jun 3, 2024 · What is silodosin? Silodosin is an alpha-blocker that is used to improve urination in men with benign prostatic hyperplasia (enlarged prostate). Silodosin may also be used for purposes not listed in this medication guide.
Silodosin: Belongs to the class of alpha-adrenoreceptor antagonists. Used in the treatment of benign prostatic hypertrophy., education |
Find patient medical information for silodosin oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
Jun 20, 2018 · Silodosin oral capsule is a prescription medication that’s used to treat benign prostatic hyperplasia (BPH), or enlarged prostate, in men. It belongs to a class of drugs called alpha-1 blockers...
Silodosin is used to treat signs and symptoms of an enlarged prostate gland, which is also known as benign enlargement of the prostate (benign prostatic hyperplasia or BPH). Benign enlargement of the prostate is a problem that can occur in men as they get older.
Silodosin is used in men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia; BPH), which include difficulty urinating (hesitation, dribbling, weak stream, and incomplete bladder emptying), painful urination, and urinary frequency and urgency.
Rapaflo (silodosin) is used to improve urination in men with benign prostatic hyperplasia (enlarged prostate). Includes Rapaflo side effects, interactions and indications.
Silodosin, sold under the brand name Urief among others, is a medication for the symptomatic treatment of benign prostatic hyperplasia. [4] [5] It acts as an alpha-1 adrenergic receptor antagonist . [4] [5]
Feb 25, 2020 · Last updated April 5, 2023. Learn about silodosin: What is it used for, what you need to know before taking, important warnings and safety info, how to take, side effects and more...
Silodosin is an antagonist of α 1 -adrenoceptors. It has the highest selectivity for the α 1A -adrenoceptor subtype, with a 162-fold greater affinity than α 1B -adrenoceptor and about a 50-fold greater affinity than for α 1D -adrenoceptor.
